Skip to search formSkip to main contentSkip to account menu

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
National Institutes of Health

Related topics

Related topics

3 relations
CHGA gene

Broader (2)

Chromogranin APeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Catestatin Prevents Macrophage-Driven Atherosclerosis but Not Arterial Injury-Induced Neointimal Hyperplasia.
Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have been… 
2012
2012
Chromogranin A-derived peptides are involved in innate immunity.
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune… 
2011
2011
Catestatin is useful in detecting patients with stage B heart failure
Screening patients with stage B heart failure(HF) may be one strategy for reducing human morbidity. To describe catestatin levels… 
2010
2010
Leukocyte telomere length and plasma catestatin and myeloid-related protein 8/14 concentrations in children with obstructive sleep apnea.
BACKGROUND Obstructive sleep apnea (OSA) is common in children and leads to multiple end-organ morbidities induced by the… 
2010
2010
Membrane structure and interactions of human catestatin by multidimensional solution and solid‐state NMR spectroscopy
Catestatin is a natural peptide of higher organisms including humans, with a wide variety of biological functions involved in… 
Highly Cited
2009
Highly Cited
2009
Global disturbances in autonomic function yield cardiovascular instability and hypertension in the chromogranin a null mouse.
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… 
2004
2004
Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A
Highly Cited
2002
Highly Cited
2002
Modulatory Mechanism of the Endogenous Peptide Catestatin on Neuronal Nicotinic Acetylcholine Receptors and Exocytosis
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited… 
2000
2000
Interaction of the catecholamine release-inhibitory peptide catestatin (human chromogranin A352-372) with the chromaffin cell surface and Torpedo electroplax: implications for nicotinic cholinergic…
1998
1998
A novel, catecholamine release-inhibitory peptide from chromogranin A: autocrine control of nicotinic cholinergic-stimulated exocytosis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)